Indication
Alcohol-related Liver Disease
1 clinical trial
4 products
Clinical trial
Effects of NNC0194-0499 Alone and in Combination With Semaglutide, of Semaglutide Alone, and of Cagrilintide Alone and in Combination With Semaglutide on Liver Damage and Alcohol Use in People With Alcohol-related Liver DiseaseStatus: Recruiting, Estimated PCD: 2025-06-18
Product
NNC0194-0499Product
SemaglutideProduct
Cagrilintide + SemaglutideProduct
Cagrilintide